Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Teva Pharma (TEVA) Gains as Billionaire Blavatnik Considers Buying Large Stake
November 6, 2017 6:41 AM ESTBeaten-down Israeli pharmaceutical stock Teva Pharma (NYSE: TEVA) is gaining 2% in pre-open trade Monday following reports over the weekend from Globes that billionaire Len Blavatnik is considering taking a large stake in the company. The report said Blavatnik may be contemplating buying Allergan's (NYSE: AGN) 10% stake.
... MoreTeva Pharma (TEVA) PT Lowered to $13 at Goldman Sachs
November 6, 2017 5:28 AM ESTGoldman Sachs lowered its price target on Teva Pharma (NYSE: TEVA) to $13.00 (from $18.00) while maintaining a Neutral rating.
Analyst Jami Rubin says significant cost restructuring is required for Teva to stabilize. The analyst expects the equity to remain under pressure until the... More
Top five unique options volume: FB SBUX FL GE TEVA
November 3, 2017 9:56 AM EDTTop five unique options volume: FB SBUX FL GE TEVA
... MoreDeutsche Bank Downgrades Teva Pharma (TEVA) to Hold
November 3, 2017 5:54 AM EDTDeutsche Bank downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold with a price target of $14.00 (from $22.00).
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $11.23 yesterday.
... MoreTeva Pharma (TEVA) PT Slashed to $10 at Cantor Fitzgerald
November 2, 2017 1:39 PM EDTCantor Fitzgerald analyst Louise Chen lowered her price target on Teva Pharma (NYSE: TEVA) to $10.00 (from $17.00) while maintaining a Neutral rating following Q3 miss and lower guide.
Chen thinks the company has some meaningful headwinds which need to be addressed before the... More
Teva Pharma (TEVA) Plunges to Fresh Low, Down 16%
November 2, 2017 9:33 AM EDTTeva Pharma (NYSE: TEVA) Plunges to Fresh Low, Down 16%
... MoreUPDATE: Teva Pharma (TEVA) Misses Q3 EPS by 4c, Q4 Guidance Comes in Light
November 2, 2017 7:00 AM EDT(Updated - November 2, 2017 7:05 AM EDT)
Teva Pharma (NYSE: TEVA) reported Q3 EPS of $1.00, $0.04 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $5.61 billion versus the consensus estimate of $5.62... More
